August 2025
Study Follow Up
19/08/25 10:13
I volunteered to be part of a study group being looked at for understanding the effects of Tecfidera on stuff outside of the MS treatment. Specially it was looking at the effects of Tecfidera on the liver. There was some information suggesting that it may have beneficial effects.
So I’ve been to a baseline study when they looked at the liver before I began taking the drug and then a three monthly review, when they looked at the same information with measurements and a FibroScan, and asked about any changes I may have had e.g. in diet etc.
Anyhoo the upshot is I have no more days to appear for the study—unless they give me a call—and just the two visits will be it. While the cirrhosis index (or whatever they called the value) remained unchanged and low/normal, the fattiness of the liver had improved by almost 20%. That’s quite cool. So who knows, people with fatty livers may one day be prescribed Tecfidera for their treatment and it wont just be an MS treatment. All data is useful, and I’m glad I volunteered.
So I’ve been to a baseline study when they looked at the liver before I began taking the drug and then a three monthly review, when they looked at the same information with measurements and a FibroScan, and asked about any changes I may have had e.g. in diet etc.
Anyhoo the upshot is I have no more days to appear for the study—unless they give me a call—and just the two visits will be it. While the cirrhosis index (or whatever they called the value) remained unchanged and low/normal, the fattiness of the liver had improved by almost 20%. That’s quite cool. So who knows, people with fatty livers may one day be prescribed Tecfidera for their treatment and it wont just be an MS treatment. All data is useful, and I’m glad I volunteered.
Comments